Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled), within 2 weeks of randomization
Within 14 days prior to registration: Total Bilirubin =< 1.5 x ULN (patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin ? 2 times upper limit of normal (ULN). (Participants with known Gilbert's disease who has serum bilirubin ? 3 × ULN may be enrolled).
Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: patients with known Gilbert disease who have serum indirect bilirubin level =< 3 X ULN may be enrolled.
Total bilirubin ? 2.0 times the upper limit of normal (ULN) of each institution with the following exception: patients with Gilbert Disease serum bilirubin > 3 x ULN.
STUDY TREATMENT: Total bilirubin =< 1.5 × upper limit of normal (ULN) within 14 days prior to the first study treatment with the following exception:\r\n* Patients with known Gilbert's disease who have serum bilirubin level =< 3 × ULN may be enrolled.
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Bilirubin =< 1.5 times the upper limit of normal (ULN) for the institution (for patients with known Gilbert's disease: bilirubin =< 3 x ULN) within 14 days of study registration
Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following the exception that patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Obtained within 14 days prior to the first study treatment (cycle 1, day 1): total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: 1) patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Within 14 days prior to cycle 1 day 1 of treatment: Bilirubin =< 1.5 x upper limit of normal (ULN) (subjects with known Gilbert’s disease who have serum bilirubin =< 3.0 x ULN may be enrolled)
Within 14 days prior to the first study treatment (cycle 1, day 1): Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception:\r\n* Patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled\r\n* Direct bilirubin =< ULN for patients with total bilirubin levels > 1.5 x ULN
Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: \r\n* Patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Total bilirubin ? 1.5 x upper limit of normal (ULN) within 14 days prior to the first study treatment (cycle 1, day 1) with the following exception:\r\n* Patients with known Gilbert disease who have serum bilirubin level ? 3 x ULN may be enrolled
Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Total bilirubin ? 1.5 × institutional upper limit of normal (ULN) (however, patients with known Gilbert’s disease who have serum bilirubin level ? 3 × ULN may be enrolled)
Serum bilirubin ? 1.5 x ULN, with the exception of patients with known Gilbert disease: serum bilirubin level ? 3 x ULN
Within 14 days prior to the first study treatment (cycle 1, day 1): Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: Patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled.
Total bilirubin =< 1.5 x upper limit of normal (ULN), obtained within 14 days prior to the first study treatment (cycle 1, day 1) with the following exception:\r\n* Patients with known Gilbert disease who have total bilirubin level =< 3 x ULN may be enrolled
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception:\r\n* Patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Patients with known Gilbert disease who have serum bilirubin level ? 3 x ULN may be enrolled.
Within 14 days of enrollment: Bilirubin =< 1.5 the upper limit of normal (ULN) for the institution\r\n* For patients with known Gilbert's disease: bilirubin =< 3 x ULN
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Within 14 days prior to the first study treatment (cycle 1, day 1): Total bilirubin =< 1.5 x upper limit of normal (ULN) with the following exception: patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Obtained within 14 days prior to the first study treatment (cycle 1, day 1); total bilirubin ? 1.5 x upper limit of normal (ULN) with the following exception: \r\n* Patients with known Gilbert disease who have serum bilirubin level ? 3 x ULN may be enrolled
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
Total bilirubin =< 1.5 x upper limit of normal (ULN) (obtained within 14 days prior to the first study treatment [course 1, day 1]) with the following exception:\r\n* Patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled
Total bilirubin must be 1.5 ULN with the following exception: Patients with known Gilbert disease who have serum bilirubin level 3 ULN may be enrolled.
Serum bilirubin =< 1.5 x ULN (patients with known Gilbert disease who have serum bilirubin level =< 3 x ULN may be enrolled)
